Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathies,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT02634970
What this trial is testing

CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab

Who this might be right for
Wet Age-related Macular Degeneration (Wet AMD)
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01958918
What this trial is testing

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 712
Not applicableLooking for participantsNCT07640997
What this trial is testing

Real-world Study of Aflibercept 8 mg in nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03423823
What this trial is testing

Ziv-aflibercept Efficacy in Better Regulating AMD

Who this might be right for
Wet Macular DegenerationWet Age-related Macular Degeneration
Kapil Kapoor 62
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Not applicableActive Not RecruitingNCT05300724
What this trial is testing

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Genentech, Inc. 400
Not applicableActive Not RecruitingNCT05690880
What this trial is testing

ForeseeHome NRich Registry

Who this might be right for
Age-Related Macular Degeneration
Notal Vision Inc. 20,000
Not applicableLooking for participantsNCT05706896
What this trial is testing

Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma

Who this might be right for
Dry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Large-scale testing (Phase 3)WithdrawnNCT00930189
What this trial is testing

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Subfoveal Choroidal Neovascularization
Asociación para Evitar la Ceguera en México
Large-scale testing (Phase 3)UnknownNCT05727397
What this trial is testing

Efficacy and Safety of RC28-E Versus Aflibercept

Who this might be right for
Wet Age-related Macular Degeneration
RemeGen Co., Ltd. 432
Not applicableActive Not RecruitingNCT04420923
What this trial is testing

Optimizing the Treatment Strategy for Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
St. Olavs Hospital 250
Testing effectiveness (Phase 2)Study completedNCT05062486
What this trial is testing

Evaluate the Safety and Efficacy of RQC for AMD

Who this might be right for
Age-related Macular Degeneration
Paul A Knepper, MD PhD 55
Not applicableUnknownNCT02345317
What this trial is testing

Reticular Pseudodrusen Progression Study

Who this might be right for
Age-related Macular Degeneration
University Hospital Muenster 30
Large-scale testing (Phase 3)UnknownNCT00454389
What this trial is testing

Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
NeoVista 494
Post-approval studies (Phase 4)Looking for participantsNCT07403825
What this trial is testing

Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

Who this might be right for
Macular Degeneration, Age Related
Biobizkaia Health Research Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT07275840
What this trial is testing

Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics Technology Limited (Shanghai R&D Center) 800
Testing effectiveness (Phase 2)Study completedNCT07501052
What this trial is testing

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Who this might be right for
Neovascular (Wet) Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema+1 more
Sam Chun Dang Pharm. Co. Ltd. 33
Not applicableStudy completedNCT05662943
What this trial is testing

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Who this might be right for
Polypoidal Choroidal VasculopathyChoroidal NeovascularizationAge-Related Macular Degeneration
Kim's Eye Hospital 135
Testing effectiveness (Phase 2)Ended earlyNCT01362348
What this trial is testing

12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
GlaxoSmithKline 19
Testing effectiveness (Phase 2)Study completedNCT00574093
What this trial is testing

Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD

Who this might be right for
Neovascular Age Related Macular Degeneration
Fondazione G.B. Bietti, IRCCS 15
Next Page